BioXcel Therapeutics, Inc. Number of Operating Segments
BioXcel Therapeutics, Inc. (BTAI) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-13
- BioXcel Therapeutics, Inc. number of operating segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BioXcel Therapeutics, Inc. number of operating segments for the quarter ending 2025-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BioXcel Therapeutics, Inc. number of operating segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BioXcel Therapeutics, Inc. number of operating segments for the quarter ending 2023-03-31 was 1.00 segment, a 0.00% change year-over-year.
- BioXcel Therapeutics, Inc. number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- BioXcel Therapeutics, Inc. number of operating segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- BioXcel Therapeutics, Inc. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- BioXcel Therapeutics, Inc. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-27 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-28 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-03-22 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-16 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-03-11 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |